Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,827 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
Chen J, Jian X, Deng S, Ma Z, Shou X, Shen Y, Zhang Q, Song Z, Li Z, Peng H, Peng C, Chen M, Luo C, Zhao D, Ye Z, Shen M, Zhang Y, Zhou J, Fahira A, Wang Y, Li S, Zhang Z, Ye H, Li Y, Shen J, Chen H, Tang F, Yao Z, Shi Z, Chen C, Xie L, Wang Y, Fu C, Mao Y, Zhou L, Gao D, Yan H, Zhao Y, Huang C, Shi Y. Chen J, et al. Among authors: luo c. Nat Commun. 2023 Aug 23;14(1):5128. doi: 10.1038/s41467-023-40833-6. Nat Commun. 2023. PMID: 37612270 Free PMC article. No abstract available.
c-MET kinase inhibitors: a patent review (2011 - 2013).
Zhu K, Kong X, Zhao D, Liang Z, Luo C. Zhu K, et al. Among authors: luo c. Expert Opin Ther Pat. 2014 Feb;24(2):217-30. doi: 10.1517/13543776.2014.864279. Epub 2013 Nov 25. Expert Opin Ther Pat. 2014. PMID: 24266843 Review.
Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
Chen J, Jian X, Deng S, Ma Z, Shou X, Shen Y, Zhang Q, Song Z, Li Z, Peng H, Peng C, Chen M, Luo C, Zhao D, Ye Z, Shen M, Zhang Y, Zhou J, Fahira A, Wang Y, Li S, Zhang Z, Ye H, Li Y, Shen J, Chen H, Tang F, Yao Z, Shi Z, Chen C, Xie L, Wang Y, Fu C, Mao Y, Zhou L, Gao D, Yan H, Zhao Y, Huang C, Shi Y. Chen J, et al. Among authors: luo c. Nat Commun. 2018 Aug 9;9(1):3171. doi: 10.1038/s41467-018-05275-5. Nat Commun. 2018. PMID: 30093687 Free PMC article.
BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
Shi C, Ye Z, Han J, Ye X, Lu W, Ji C, Li Z, Ma Z, Zhang Q, Zhang Y, He W, Chen Z, Cao X, Shou X, Zhou X, Wang Y, Zhang Z, Li Y, Ye H, He M, Chen H, Cheng H, Sun J, Cai J, Huang C, Ye F, Luo C, Zhou B, Ding H, Zhao Y. Shi C, et al. Among authors: luo c. Neuro Oncol. 2020 Aug 17;22(8):1114-1125. doi: 10.1093/neuonc/noaa084. Neuro Oncol. 2020. PMID: 32246150 Free PMC article.
The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C, Xu W, Ding H, Chen Z, Shi C, Han J, Yu L, Qiao N, Zhang Y, Cao X, Zhou X, Cheng H, Feng H, Luo C, Li Z, Zhou B, Ye Z, Zhao Y. Ji C, et al. Among authors: luo c. J Clin Endocrinol Metab. 2022 May 17;107(6):e2291-e2300. doi: 10.1210/clinem/dgac128. J Clin Endocrinol Metab. 2022. PMID: 35247260 Free PMC article.
Natural product P57 induces hypothermia through targeting pyridoxal kinase.
Wang R, Xiao L, Pan J, Bao G, Zhu Y, Zhu D, Wang J, Pei C, Ma Q, Fu X, Wang Z, Zhu M, Wang G, Gong L, Tong Q, Jiang M, Hu J, He M, Wang Y, Li T, Liang C, Li W, Xia C, Li Z, Ma DK, Tan M, Liu JY, Jiang W, Luo C, Yu B, Dang Y. Wang R, et al. Among authors: luo c. Nat Commun. 2023 Sep 26;14(1):5984. doi: 10.1038/s41467-023-41435-y. Nat Commun. 2023. PMID: 37752106 Free PMC article.
7,827 results